Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-01-04 @ 1:08 AM
Study NCT ID:
NCT03257267
Status:
COMPLETED
Last Update Posted:
2025-04-08
First Post:
2017-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Cemiplimab in Adults With Cervical Cancer
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-26
First Submit QC Date:
None
Study First Post Date:
2017-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-03-11
Results First Submit QC Date:
None
Results First Post Date:
2022-04-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-04
Last Update Post Date:
2025-04-08
Last Update Post Date Type:
ACTUAL